Why the study?
Do the IDF and NCEP ATP III definitions of the metabolic syndrome accurately predict coronary heart disease in subjects with type 2 diabetes?
Do the IDF and NCEP ATP III definitions of the metabolic syndrome accurately predict coronary heart disease in subjects with type 2 diabetes?
The IDF definition of metabolic syndrome may not be an effective tool for identifying the highest risk subgroup for coronary heart disease in patients who already have established type 2 diabetes.
IDF criteria should not yet stratify CHD risk in type 2 diabetes; leaves open whether alternative definitions improve prediction.
With established type 2 diabetes, the IDF definition of the metabolic syndrome failed to identify a subgroup of patients who had the highest risk for CHD. Practitioners must recognize the appropriate setting for its application.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: